NCT00381082View on ClinicalTrials.gov

A Randomised, Assessor-Blind, Comparative Efficacy Clinical Trial of 3 Pediculicides.

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

152

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

November 30, 2004

Conditions

Pediculosis

Interventions

DRUG

1) MOOV Head Lice Treatment (Ego Pharmaceutical).

DRUG

Banlice Mousse Aerosol (Pfizer, Australia)

DRUG

3) KP24 Medicated Foam (Nelson Laboratories)

Trial Locations (1)

4072

University of Queensland, Brisbane

Sponsors

Collaborators (1)

Ego Pharmaceuticals

All Listed Sponsors

collaborator

Ego Pharmaceuticals

INDUSTRY

lead

Uniquest Pty Ltd

OTHER